Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
Neuropeptide Y (NPY) | ||||||
Neuropeptide Y (NPY) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Antagonist ([D-Trp32]NPY) of Npy | |||||
Induced Change | Norepinephrine concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that antagonist [D-Trp32]NPY of Npy leads to the increase of norepinephrine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Npy | |||||
Induced Change | Norepinephrine concentration: increase (FC = 1.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Npy leads to the increase of norepinephrine levels compared with control group. | |||||
Oxidoreductases (EC 1) | ||||||
Formyltetrahydrofolate dehydrogenase (ALDH1L2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Mutation of ALDH1L2 | |||||
Induced Change | Norepinephrine concentration: increase (FC = 4) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Genetic disorders of keratinisation [ICD-11: EC20] | |||||
Details | It is reported that mutation (patients) of ALDH1L2 leads to the increase of norepinephrine levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Norepinephrine concentration: increase (Log2 FC=1.72) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the increase of norepinephrine levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.